Welcome to InfiCure Bio
InfiCure Bio is a life science company focusing on preclinical development and validation of drugs that target chronic inflammatory and fibrotic conditions.
Based on a panel of in vivo models for these conditions including a proprietary model, the NIF mouse, for chronic inflammation and fibrosis, we offer effect tests of anti-inflammatory and anti-fibrotic drugs.
Founded on extensive experience and expertise in immunology, inflammation and fibrosis research, InfiCure Bio offers a proficient and flexible processing of drug validation projects in this area.
News
Lena Söderström speaks at LXS Nordic Congress 8th of September
Lena Söderström, Head of board at InfiCureBio, will share her views on listing of companies. Take the opportunity to listen to her experiences!
InfiCure Bio will participate with a poster at EASL NAFLD Summit on September 16-17
Inficure Bio will attend the EASLE NAFLD Summit, and present a poster on the NIF mouse. Don't miss the opportunity to take part of the latest updates on how to use the NIF mouse for [...]
We at InfiCure Bio wish you all a wonderful summer!
Present and former members of InfiCure Bio rounded up before summer holidays with a lunch in the sun in central Umeås beautiful park. We now look forward to a relaxing holiday and will return with [...]
Sofia Mayans will present at the 4th Global NASH Congress, April 28-29
Don't miss the presentation by Sofia Mayans at the virtual 4th Global NASH Congress, April 28 at 12.45, where she will share the latest discoveries on our unique NIF liver model!